BE1000168A3 - Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. - Google Patents

Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. Download PDF

Info

Publication number
BE1000168A3
BE1000168A3 BE8700817A BE8700817A BE1000168A3 BE 1000168 A3 BE1000168 A3 BE 1000168A3 BE 8700817 A BE8700817 A BE 8700817A BE 8700817 A BE8700817 A BE 8700817A BE 1000168 A3 BE1000168 A3 BE 1000168A3
Authority
BE
Belgium
Prior art keywords
weight
sorbitol
pharmaceutical composition
acetyl
aspartame
Prior art date
Application number
BE8700817A
Other languages
English (en)
French (fr)
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Original Assignee
Inpharzam Internat Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam Internat Sa filed Critical Inpharzam Internat Sa
Application granted granted Critical
Publication of BE1000168A3 publication Critical patent/BE1000168A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE8700817A 1986-07-24 1987-07-23 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. BE1000168A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Publications (1)

Publication Number Publication Date
BE1000168A3 true BE1000168A3 (fr) 1988-07-05

Family

ID=4245819

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700817A BE1000168A3 (fr) 1986-07-24 1987-07-23 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol.

Country Status (8)

Country Link
BE (1) BE1000168A3 (it)
CH (1) CH666814A5 (it)
DE (1) DE3723734A1 (it)
FR (1) FR2601875B1 (it)
GB (1) GB2192789B (it)
IT (1) IT1222103B (it)
NL (1) NL194154C (it)
SE (1) SE500493C2 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (it) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
DE4329857C2 (de) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Verbindung zur Stärkung des Immunsystems und von Immunreaktionen
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
WO2000018392A1 (en) * 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
CN1320160A (zh) 1998-09-25 2001-10-31 格利科克斯有限公司 果糖胺氧化酶测定的方法和材料
EP1293251A1 (en) * 2001-09-14 2003-03-19 Holland Sweetener Company V.o.F. Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder
EP2500018B1 (en) 2002-03-08 2017-07-19 PhilERA New Zealand Limited Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
US20060100278A1 (en) 2002-08-20 2006-05-11 Cooper Garth J S Dosage forms and related therapies
CA2875095C (en) 2004-07-19 2019-09-03 Philera New Zealand Limited Synthesis of triethylenetetramines
GR1007236B (el) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN103142505B (zh) * 2013-03-29 2015-03-11 山东罗欣药业集团股份有限公司 一种乙酰半胱氨酸组合物颗粒剂及其制备方法
ES2877679T3 (es) 2017-12-31 2021-11-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composición farmacéutica que comprende acetilcitisteína sin metilparabeno ni propilparabeno
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (de) * 1967-05-24 1971-05-13 Miles Lab Tablettenbindemittel
EP0125634A1 (de) * 1983-05-13 1984-11-21 Reichert, Dietrich, Dr. med. Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (de) * 1967-05-24 1971-05-13 Miles Lab Tablettenbindemittel
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use
EP0125634A1 (de) * 1983-05-13 1984-11-21 Reichert, Dietrich, Dr. med. Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DICTIONNAIRE VIDAL, 61ième édition, 1985, page 551, O.V.P. Paris, FR; "Exomuc" *

Also Published As

Publication number Publication date
GB8717581D0 (en) 1987-09-03
IT8721410A0 (it) 1987-07-23
NL194154B (nl) 2001-04-02
FR2601875A1 (fr) 1988-01-29
CH666814A5 (it) 1988-08-31
SE8702941D0 (sv) 1987-07-23
GB2192789A (en) 1988-01-27
SE500493C2 (sv) 1994-07-04
DE3723734A1 (de) 1988-02-04
FR2601875B1 (fr) 1992-02-21
NL194154C (nl) 2001-08-03
IT1222103B (it) 1990-08-31
NL8701744A (nl) 1988-02-16
SE8702941L (sv) 1988-01-25
GB2192789B (en) 1990-01-31
DE3723734C2 (it) 1992-05-21

Similar Documents

Publication Publication Date Title
BE1000168A3 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol.
FR2601876A1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
JP2874967B2 (ja) 本質的に水に不溶な薬剤活性体のための薬剤水懸濁液
AU707210B2 (en) Fluoxetine pharmaceutical formulations
US4760094A (en) Spray dried acetaminophen
AT396426B (de) Feste pharmazeutische ranitidinpräparate
BE1015217A5 (it)
EP0481294B2 (de) Feste, schnell-lösliche Arzneimittelzubereitung enthaltend N-Acetylcystein
EP0759296B1 (de) Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
FR2724844A1 (fr) Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
CA2017360A1 (fr) Forme pharmaceutique poreuse et sa preparation
CA2403594A1 (en) Granules having good taking property
CZ170296A3 (en) Organoleptic acceptable pharmaceutical preparation for peroral administration
JP2705787B2 (ja) 苦味改善易服用性ｈ▲２▼ブロッカー固形製剤
JP2007131561A (ja) 経口固形製剤及びその製造法
ES2340779T3 (es) Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
KR100929320B1 (ko) 리바비린 시럽 제형
JPS62153220A (ja) 胆汁酸内用水剤
KR101175120B1 (ko) 나테글리니드 함유 제제
EP1129709B1 (en) Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof
EP0468245B1 (de) Tablette und Granulat welche als Wirkstoff Mesna enthalten
EA012324B1 (ru) Быстрораспадающаяся таблетка
JP2006131625A (ja) 味質の改善されたイソソルビド製剤
JP3995202B2 (ja) 経口用ウコン類組成物
HU191542B (en) Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: S.A. *INPHARZAM

Effective date: 20070723